Cargando…
Airway Epithelial-Derived Immune Mediators in COVID-19
The airway epithelium, which lines the conducting airways, is central to the defense of the lungs against inhaled particulate matter and pathogens such as SARS-CoV-2, the virus that causes COVID-19. Recognition of pathogens results in the activation of an innate and intermediate immune response whic...
Autores principales: | Guo, Tony J. F., Singhera, Gurpreet K., Leung, Janice M., Dorscheid, Delbert R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458661/ https://www.ncbi.nlm.nih.gov/pubmed/37631998 http://dx.doi.org/10.3390/v15081655 |
Ejemplares similares
-
Expression of surfactant protein D in airways of asthmatics and interleukin-13 modulation of surfactant protein D in human models of airway epithelium
por: Xu, Jie, et al.
Publicado: (2015) -
Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells
por: Yang, Nan, et al.
Publicado: (2021) -
IL-13Rα2/AP-1 complex signalling mediates airway epithelial repair without effects on remodeling pathways
por: Yang, Jasemine S, et al.
Publicado: (2010) -
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
por: Leung, Janice M., et al.
Publicado: (2020) -
Apoptosis of viral-infected airway epithelial cells limit viral production and is altered by corticosteroid exposure
por: Singhera, Gurpreet K, et al.
Publicado: (2006)